Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss in Cronkhite-Canada syndrome is reversible by treating the gut issues and doesn't need steroid treatment for the hair itself.

Hair loss in a drug reaction case involved both a common shedding phase and an immune attack on hair follicle stem cells.

The study concludes that traction alopecia, caused by hair styling, can help understand telogen effluvium, a condition of excessive hair loss.

A woman experienced unusual hair loss and skin reactions after taking phenobarbital, but her hair grew back after treatment.

Hair loss in Cronkhite-Canada syndrome may be due to an autoimmune response.

The "color-transition sign" helps tell apart alopecia areata incognita from telogen effluvium by looking at hair color changes.

Telogen effluvium is a reversible hair loss condition that requires a detailed diagnosis and often resolves on its own.

Telogen effluvium is a common type of hair loss that can resolve on its own or become chronic, with treatment depending on early diagnosis.

Hair loss in Cronkhite-Canada syndrome may be caused by autoimmune factors, not just stress or malabsorption.

Telogen Effluvium is a condition causing excessive hair loss due to stress, illness, drugs, or hormonal changes, and can be treated with specific products or naturally resolves after 3-4 years.

Experts discussed hair care, genetic hair defects, hair loss treatments, nail surgery, lupus treatments, skin infections, and cosmetic allergies.

Hair disorders are caused by a complex mix of biology, genetics, hormones, and environmental factors, affecting hair growth and leading to conditions like alopecia.

The report suggests that hair loss in Cronkhite-Canada syndrome may be caused by alopecia areata incognita, as shown by a patient's improvement with treatment.

A patient with Cronkhite-Canada syndrome improved with nutritional support and steroids, but early diagnosis is key due to high mortality.

Hair transplantation successfully treated a woman's hair loss caused by a tight ponytail.

Chemotherapy causes hair loss starting soon after treatment begins and recovers about 3 months after ending, while tamoxifen does not significantly affect hair growth.

Mood stabilizers can cause serious skin reactions; careful monitoring and immediate treatment are crucial.

Skin reactions to antidepressants are common but usually not serious and can be treated.

Alopecia areata involves immune response and gene changes affecting hair loss.

There is no standard treatment for the rare Cronkhite–Canada syndrome, which can be fatal and lead to cancer.

Hair and scalp pain is more common and severe in breast cancer patients on chemotherapy than those on tamoxifen.

A patient with Cronkhite-Canada Syndrome developed colon cancer that spread to the liver, showing the need for regular cancer checks in such patients.

Researchers found a new mutation in the HR gene causing hair loss and skin bumps in a Pakistani family.

Sodium hypochlorite can effectively prevent and remove Staphylococcus aureus biofilms in atopic dermatitis at high enough concentrations.

Mais estudos são necessários para garantir a eficácia e qualidade dos tratamentos de alopecia com plantas medicinais.

The document concludes that scalp conditions have various causes and can present in many different ways.

Different types of persistent hair loss after chemotherapy respond differently to treatments.

A woman's skin darkened after using dutasteride and pimecrolimus for hair loss, but improved when she stopped the medications and protected her skin from light.

Cronkhite-Canada syndrome is rare, has a poor prognosis, and requires early diagnosis and ongoing treatment.

AA–TF#15 significantly promotes hair regrowth and could be an effective treatment for androgenic alopecia.